0 Комментарии
0 Поделились
1126 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
- Войдите, чтобы отмечать, делиться и комментировать!
- Biosimilars Market Growth Accelerated by Increasing Demand for Cost-Effective DrugsBiosimilars are biopharmaceutical drugs that are similar to an already approved biological drug, known as reference biologic drug or brand-name biologic. Biosimilars help reduce healthcare costs as they can be priced lower than reference biologics. Biosimilars have large-molecule structures that are similar but not identical to approved biological drugs, exhibiting lesser side effects. The...0 Комментарии 0 Поделились 585 Просмотры 0 предпросмотр
- Biosimilars Market Is Estimated To Witness High Growth Owing To Increasing Demand for Cost-effective Treatment OptionsThe global Biosimilars Market is estimated to be valued at US$ 29.4 Bn in 2023 and is expected to exhibit a CAGR of 17.8% over the forecast period 2023-2028, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: The Biosimilars Market refers to the pharmaceutical market that deals with the development and production of biosimilar drugs. Biosimilars are...0 Комментарии 0 Поделились 1726 Просмотры 0 предпросмотр
- Global Biosimilars Market Is Estimated To Witness High Growth Owing To Increasing Demand for Cost-effective Treatment Options and Expanding Biologics MarketThe Biosimilars Market is estimated to be valued at USD 21.8 billion in 2023 and is expected to exhibit a CAGR of 15.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: The Biosimilars Market offers cost-effective treatment options that are comparable to the originator biologics. These biosimilars are highly similar to the...0 Комментарии 0 Поделились 1070 Просмотры 0 предпросмотр
- Herceptin Biosimilars Market Size, Share, Demand, Future Growth, Challenges and Competitive Analysis"Global Herceptin Biosimilars Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. The document also explains key elements such as revenue, business distribution, market share, shipment, gross profit, and more. All these elements help the readers to understand...0 Комментарии 0 Поделились 40 Просмотры 0 предпросмотр
- Herceptin Biosimilars Market Size, Share, Trends, Key Drivers, Demand and Opportunity AnalysisGlobal Herceptin Biosimilars Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. The document also explains key elements such as revenue, business distribution, market share, shipment, gross profit, and more. All these elements help the readers to understand...0 Комментарии 0 Поделились 106 Просмотры 0 предпросмотр
- Oncology Biosimilars Market Industry Size, Growth, Demand, Opportunities and Forecast By 2029Oncology Biosimilars report puts across the idea of high level analysis of major market segments and identification of opportunities.Market analysis and market segmentation has been carried out in terms of markets, geographic scope, years considered for the study, currency and pricing, research methodology, primary interviews with key opinion leaders, DBMR market position grid, DBMR market...0 Комментарии 0 Поделились 1000 Просмотры 0 предпросмотр
- Peptide Therapeutics Market Driven By Rising Demand For Biologics And BiosimilarsThe Peptide Therapeutics market overview comprises therapeutic peptides that mimic the natural peptides in the human body for various therapeutic applications. Some key therapeutic peptides include liraglutide, exenatide, oxytocin, and insulin. These peptides help in treating diseases like cancer, metabolic disorders, cardiovascular ailments among others. The rising incidence of chronic...0 Комментарии 0 Поделились 593 Просмотры 0 предпросмотр
- Remicade Biosimilars Market Poised to Witness High Growth Due to Rising Demand for Cost-Effective BiologicsThe global Remicade Biosimilars Market is estimated to be valued at US$ 3007 million in 2023 and is expected to exhibit a CAGR of 3.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. SWOT Analysis Strength: Remicade biosimilars are nearly identical versions of original biologic drugs and provide a more...0 Комментарии 0 Поделились 807 Просмотры 0 предпросмотр
- Sterile Injectables Market Is Estimated To Witness High Growth Owing To Increasing Demand Of BiosimilarsThe sterile injectables market is estimated to be valued at US$ 213 Bn in 2023 and is expected to exhibit a CAGR of 9.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Sterile injectables refer to medical devices or drug products that are administered into the body through injection by sterile syringes and vials. They...0 Комментарии 0 Поделились 713 Просмотры 0 предпросмотр
- Automation Set To Accelerate Growth Of The Global Biosimilars MarketThe global Biosimilars Market is estimated to be valued at US$ 29.4 Bn in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Biosimilars are biologics that are highly similar to an approved biological drug known as the reference biologic product. Biosimilars offer advantages...0 Комментарии 0 Поделились 868 Просмотры 0 предпросмотр
- Biosimilars Market Surges to USD 88.43 Billion by 2030, Propelled by 16.67% CAGRThe report named, "Global Biosimilars Market Research Report 2024" has been added to the archive of market research studies by marketreportservice. The industry experts and researchers have offered reliable and precise analysis of the global Biosimilars market in view of numerous aspects such as growth factors, challenges, limitations, developments, trends, and growth opportunities. This...0 Комментарии 0 Поделились 185 Просмотры 0 предпросмотр
- Remicade Biosimilars Market Estimated To Witness High Growth Owing To Rising Prevalence Of Autoimmune DiseasesSWOT Analysis Strength: Remicade biosimilars market has strong growth potential due to the patent expiry of Remicade leading to availability of affordable treatment options. Biosimilars have almost similar efficacy as reference biologics with much lower costs. Rapid regulatory approvals for biosimilars are catalyzing their commercialization. Weakness: Development of biosimilars require...0 Комментарии 0 Поделились 801 Просмотры 0 предпросмотр
- Remicade Biosimilars Market is Estimated to Witness High Growth Owing to Increased Use for the Treatment of Rheumatoid ArthritisRemicade is a biologic disease-modifying anti-rheumatic drug used for the treatment of various autoimmune diseases. It is primarily used for rheumatoid arthritis, Crohn's disease, ulcerative colitis. Remicade biosimilars offer effective treatment alternatives at lower costs. This has increased the use of Remicade biosimilars in recent years. The global Remicade biosimilars Market is estimated...0 Комментарии 0 Поделились 743 Просмотры 0 предпросмотр
- The MENA Biologics & Biosimilars Market will grow at highest pace owing to increasing healthcare expenditureThe MENA biologics and biosimilars market consists of large molecule drugs produced or extracted from living organisms used for the treatment of various chronic diseases. biologics help treat diseases such as cancer, diabetes, autoimmune disorders, etc. They are made from living cells and are often the only treatment option for life-threatening illnesses. Biosimilars provide more affordable...0 Комментарии 0 Поделились 595 Просмотры 0 предпросмотр
- The Mena Biologics and Biosimilars Market is Estimated to Witness High Growth owing to Increasing Uptake of BiosimilarsThe Mena Biologics and Biosimilars Market is estimated to be valued at US$ 502.2 Mn in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Mena biologics and biosimilars market consists of biologic drug products primarily used for the treatment of chronic diseases like...0 Комментарии 0 Поделились 1005 Просмотры 0 предпросмотр
Расширенные страницы